Yes, Melanotan II has been widely studied in preclinical models related to melanin production
Calmness (00:13:44) Hypothalamic-Pituitary-Adrenal Axis (HPA axis) (00:17:36) The Threat Reflex: Neural Circuits for Fear (00:28:24) Controlling Fear: Top-Down Processing (00:32:27) Narratives: Protective or Dangerous (00:35:58) Attaching Fear to Events: Classical Conditioning & Memory (00:41:45) How Fear Learning Occurs: Long Term Potentiation, NMDA (00:46:10) Extinguishing (Reducing) Fears (00:50:25) Cognitive (Narrative) Therapies for Fear (00:57:56) Repetition of Narrative, Overwriting Bad Experiences with Good (01:05:28) EMDR: Eye Movement Desensitization Reprocessing (01:14:00) Social Connection & Isolation Are Chemically Powerful (01:18:23) Trans-Generational Trauma (01:25:00) PTSD Treatments: Ketamine, MDMA, oxytocin (01:39:25) How Do You Know If You Are Traumatized
semaglutide: clinical decision-making in the GLP-1 landscape Tirzepatide Versus Semaglutide on Weight Loss in Type 2 Diabetes Patients: A Systematic Review and Meta-Analysis of Direct Comparative Studies Tirzepatide: A Systematic Update Efficacy and safety of tirzepatide, dual GLP-1/GIP receptor agonists, in the management of type 2 diabetes: a systematic review and meta-analysis of randomized controlled trials Tirzepatide, a dual GIP/GLP-1 receptor agonist, alleviates metabolic dysfunction-associated steatotic liver disease by reducing the expression of CD36 and OBP2A
Individual results vary So we offer sustainable treatment plans
"If I feel nauseous, it's working better." Not necessarily
Used in integrative oncology settings in conjunction with conventional cancer treatment
